Volume 5, Issue 3
Editorialp. 139-143
Microbe-based approaches for the treatment of diabetes
Author(s): Mikael Knip & Heli Siljander
Editorialp. 144-146
An anthropological insight into the Pacific island diabetes crisis and its clinical implications
Author(s): Amy K McLennan & Stanley J Ulijaszek
News and Viewsp. 147-149
Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of diabetes management
Author(s): Li Zhang, Shazli Azmi, Maryam Ferdousi, Richard W Grant & Hong Xiao
Commentaryp. 154-159
Diabetes in treated hepatitis C infection: dodging the sweet sting
Author(s): Victoria Harris & Katherine Samaras
Perspective Articlep. 167-181
Patients nonadherence and doctors clinical inertia: two faces of medical irrationality
Author(s): Gerard Reach
Drug Evaluationp. 183-201
Canagliflozin for the treatment of adults with Type 2 diabetes
Author(s): Gary Meininger, William Canovatchel, David Polidori & Norm Rosenthal
Review Articlep. 202-212
The role of reactive oxidative species in insulin resistance-associated cardiovascular disease
Author(s): Noman Ali, Mark T Kearney & Richard M Cubbon
Review Articlep. 215-227
Childhood-onset Type 1 diabetes and cardiovascular disease
Author(s): Reena Perchard & Rakesh Amin
Review Articlep. 228-242
Role of sodium status in the clinical management of diabetic nephropathy: interaction with RAAS-blockade efficacy
Author(s): Martin H de Borst & Gerjan Navis
